Discover the future of schizophrenia research. Join CenExel experts Dr. David Walling and Dr. Lara Shirikjian as they explore recent breakthroughs, trial innovations, and what’s next for schizophrenia care in 2026 and beyond.
Schizophrenia research is at an inflection point. Over the past few years, the field has experienced a wave of innovation, both in therapeutic development and in the way that trials are designed and conducted. As 2025 comes to a close, it is an ideal moment to reflect on the meaningful progress that has been made and to examine how these advances will shape the next phase of research in 2026 and beyond.
